A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic Patients
Clinical trial NCT01819818 · COMPLETED
Trial details
- NCT number
- NCT01819818
- Sponsor
- Janssen Korea, Ltd., Korea
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-05-23
- Primary completion
- 2019-11-29
- Enrollment
- 3267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.